Home › Funds › Samsara BioCapital, LLC › RANI

Samsara BioCapital, LLC position in RANI

Rani Therapeutics Holdings Inc Class A · Health Care

Samsara BioCapital, LLC reported holding 10,369,159 shares of RANI (Rani Therapeutics Holdings Inc Class A) in its Q2 2026 13F filing — a position valued at US$7.9M, representing 0.65% of its reported portfolio and ranking #17 among its reported holdings. Samsara BioCapital, LLC has disclosed RANI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)10.37M sh
Reported value held$7.88M
Portfolio Weight0.65%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's RANI position evolved

Samsara BioCapital, LLC first disclosed a stake in RANI in Q4 2025 at 8,500,000 shares (US$11.5M). Across 3 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 10,369,159 shares valued at US$7.9M — an increase of 1,869,159 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 8.50M $11.47M New
Q1 2026 8.50M $6.25M Hold
Q2 2026 10.37M $7.88M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RANI and 13F data

RANI (Rani Therapeutics Holdings Inc Class A) is a Health Care company. 30 other funds we track also report a position in RANI — the largest reported positions include SymBiosis Capital Partners, LLC (US$2.7M), Nan Fung Group Holdings Ltd (US$375K), UNITED SERVICES AUTOMOBILE ASSOCIATION (US$230K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RANI

All RANI fund holders →

FAQ

How long has Samsara BioCapital, LLC held RANI?

Samsara BioCapital, LLC has disclosed RANI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Samsara BioCapital, LLC's current position in RANI?

As of Q2 2026, Samsara BioCapital, LLC holds 10.37M shares of RANI (Rani Therapeutics Holdings Inc Class A), valued at $7.88M, representing 0.65% of its reported portfolio and ranking #17.

Has Samsara BioCapital, LLC been buying or selling RANI?

In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC increased its position in RANI.

Which other funds hold RANI?

Other major institutional holders of RANI include SymBiosis Capital Partners, LLC, Nan Fung Group Holdings Ltd, UNITED SERVICES AUTOMOBILE ASSOCIATION, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.